Literature DB >> 8749130

Bilateral loss of vestibular function.

T Rinne1, A M Bronstein, P Rudge, M A Gresty, L M Luxon.   

Abstract

The clinical findings in 53 patients with bilateral vestibular failure (BVF) seen in a neurological hospital are reported. Bilateral acoustic neuromas were excluded. Seven patients (13%) had progressive cerebellar degeneration; these patients had no hearing complaints but showed gait ataxia, abnormal eye movements and cerebellar atrophy on neuro-imaging. Referral in these patients was primarily for eye movement assessment, and BVF was usually unsuspected. Neuropathies were present in 5 patients (9%), usually with normal central (brainstem-cerebellar) ocular motor function and variable patterns of hearing loss. The single largest group was idiopathic BVF (11 patients, 21%), patients presenting with vertiginous episodes, progressive unsteadiness or brief paroxysms of oscillopsia; auditory function, eye movements, neurological examination and imaging were usually normal. Nine patients (17%) suffered ototoxicity, mostly due to gentamicin; hearing was normal or mildly impaired. In 6 patients (11%) BVF was post-meningitic, with concomitant auditory loss. Autoimmune disease was found in 5 patients (9%); other organs were involved by the disease, and hearing was impaired but eye movements were spared. Miscellaneous neurological, otological or neoplastic diseases accounted for the remaining 10 patients. This study suggests that i) in patients with cerebellar degenerations, BVF may be underdiagnosed as the unsteadiness may be attributed only to the cerebellar disorder, ii) some patients with idiopathic BVF present with only minor visual or vestibular symptoms, and iii) detailed immunological screenings should be undertaken more often, in view of the significant proportion of patients with autoimmune and idiopathic BVF.

Entities:  

Mesh:

Year:  1995        PMID: 8749130     DOI: 10.3109/00016489509125239

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  9 in total

1.  Aminoglycoside ototoxicity: Vestibular function is also vulnerable.

Authors:  Barry M Seemungal; Adolfo M Bronstein
Journal:  BMJ       Date:  2007-11-10

2.  Novel subtype of idiopathic bilateral vestibulopathy: bilateral absence of vestibular evoked myogenic potentials in the presence of normal caloric responses.

Authors:  Chisato Fujimoto; Toshihisa Murofushi; Yasuhiro Chihara; Mitsuya Suzuki; Tatsuya Yamasoba; Shinichi Iwasaki
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

3.  EMG responses to free fall in elderly subjects and akinetic rigid patients.

Authors:  A R Bisdorff; A M Bronstein; C Wolsley; M A Gresty; A Davies; A Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

4.  Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome.

Authors:  D J Szmulewicz; J A Waterston; G M Halmagyi; S Mossman; A M Chancellor; C A McLean; E Storey
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

Review 5.  Vertigo and autoimmunity.

Authors:  Roberto Bovo; Andrea Ciorba; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-16       Impact factor: 2.503

6.  Vestibular rehabilitation with electrotactile vestibular substitution: early effects.

Authors:  Alev Uneri; Senol Polat
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-11       Impact factor: 2.503

7.  Vestibular reflexes and positional manoeuvres.

Authors:  A M Bronstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

8.  Prevention of Severe Vestibular Hypofunction after Systemic Gentamicin.

Authors:  Sofía Ferreira-Cendon; Ramon Martinez-Carranza; Maria José Fernandez-Nava; Rosana Villaoslada-Fuente; Hortensia Sanchez-Gomez; Santiago Santa Cruz-Ruiz; María Sanchez-Ledesma; Angel Batuecas-Caletrio
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

9.  Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Bárány Society.

Authors:  Michael Strupp; Ji-Soo Kim; Toshihisa Murofushi; Dominik Straumann; Joanna C Jen; Sally M Rosengren; Charles C Della Santina; Herman Kingma
Journal:  J Vestib Res       Date:  2017       Impact factor: 2.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.